November 25, 2025
AbbVie and adMare BioInnovations – Foster Life Sciences Innovation with the Launch of the AbbVie Biotech Innovators Award in Quebec
Member Press Releases
Read More
November 24, 2025
CSL Seqirus – Enhanced Influenza Vaccines Provide Essential Protection for Older Adults: CSL Seqirus Presents New Evidence Supporting Broader Adoption Across Europe
Member Press Releases
Read More
November 24, 2025
NervGen Pharma – Announces Expanded CONNECT SCI Study Data Demonstrating Unprecedented Durable Improvement in Function, Independence, and Quality of Life in Chronic Spinal Cord Injury
Member Press Releases
Read More
November 21, 2025
Kapoose Creek Bio – Recent awards power two new studies into drug discovery and development
Member Press Releases
Read More
November 19, 2025
BIOTECanada responds to the pCPA`s ENP & TNP Process consultations
Statements & Submissions
Read More
November 17, 2025
Zymeworks – Announces Positive HERIZON-GEA-01 Phase 3 Results Supporting Ziihera® (zanidatamab-hrii) as HER2-Targeted Agent-of-Choice and New Standard of Care in First-Line HER2-Positive Locally Advanced or Metastatic Gastroesophageal Adenocarcinoma
Member Press Releases
Read More
November 6, 2025
BIOVECTRA and Revolution Biomanufacturing – Partner to Deliver Integrated mRNA Design and GMP Production Services — Partnership Combines Sequence Design Expertise with End-to-End GMP Manufacturing to Streamline mRNA Development and Scale-up
Member Press Releases
Read More
November 5, 2025
Grounding the resilience of global biotech supply chains
Speaking Engagements
Read More
November 5, 2025
GSK – Survey Highlights Gaps in RSV Awareness, Risk Understanding Among Vulnerable Older Canadian Adults
Member Press Releases
Read More
November 4, 2025
Federal Budget Delivers Breakthrough Wins for Canada’s Life Sciences Sector
Press Releases
Read More
November 4, 2025
Optigo Biotherapeutics – Renowned Pharma and Biotech Development Leader, Dr. Andreas Wallnöfer, is named to Optigo Biotherapeutics’ Board of Directors as the company advances to IND-enabling studies.
Member Press Releases
Read More
October 28, 2025
Neurenati Therapeutics Inc. – The EMA Grants Orphan Drug Designation to Neurenati’s NEU-001 for the Treatment of Hirschsprung Disease
Member Press Releases
Read More
October 27, 2025
Eisai – Health Canada Grants Authorization for LEQEMBI® (lecanemab) for the Treatment of Early Alzheimer’s Disease
Member Press Releases
Read More
October 23, 2025
Pfizer Canada – ABRYSVO Receives Expanded Public Funding Across Canadian Provinces for 2025-2026 RSV Season
Member Press Releases
Read More
October 22, 2025
Sanofi-Aventis Canada Inc. – Dupixent® (dupilumab injection) approved in Canada for adults with inadequately controlled Chronic Obstructive Pulmonary Disease (COPD)
Member Press Releases
Read More
October 20, 2025
Turning innovation into impact: Canada’s biotech advantage
Media Mentions
Read More
October 17, 2025
Bio-Europe Supplement: Canada’s Life Sciences Leadership: partnering for global impact
Media Mentions
Read More
October 16, 2025
ME THERAPEUTICS – GRANTED LICENCE FOR CD22 NANOBODY ASSET TO EXPAND NEXT-GEN IN VIVO CAR CELL THERAPY PROGRAM
Member Press Releases
Read More
1 2 3 4 5 6 … 12